Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery



Status:Not yet recruiting
Conditions:Post-Surgical Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:18 - 40
Updated:3/21/2019
Start Date:May 2019
End Date:June 2020
Contact:Francesca Tesone, DMD
Email:ftesone@bu.edu
Phone:(617)-638-4350

Use our guide to learn which trials are right for you!

Does Bupivacaine Liposomal Injectable Suspension Decrease Post-operative Pain and Narcotic Use After Elective Orthognathic Surgery?

This research is being done to determine quantitative and qualitative differences in
patients' post-operative pain levels following elective orthognathic surgery after the local
administration of a liposomal bupivacaine injection.

A primary objective is to determine whether using a liposomal bupivacaine injection placed
locally at the conclusion of elective orthognathic surgery will decrease pain levels (as
determined by VAS scores). A secondary objective is to examine whether using a long acting
liposomal bupivacaine injection locally at the conclusion of elective orthognathic surgery
leads to decreased use of narcotics post-operatively.

Participants in Group 1 (study group) will receive ExparelTM (133 mg/10 ml - 4 ml into the
maxilla, and 6 ml into the mandible). This will be injected into the soft tissue and gingiva
surrounding the surgical site at the time of wound closure. Participants in Group 2 (standard
of care) will receive bupivacaine 0.5% (4 ml into the maxilla, and 6 ml into the mandible)
injected into the soft tissue and gingiva surrounding the surgical site at the time of wound
closure.

Post-operatively, all participants will be cared for utilizing the current standard
post-operative pain management protocol for all patients undergoing elective orthognathic
surgery at Boston Medical Center. This consists of acetaminophen 325 mg given every 4 hours
as a scheduled medication; patients also receive an additional 325 mg of acetaminophen for a
reported pain level of 1-3, 5 mg of oxycodone for a reported pain level of 4-6, and 10 mg of
oxycodone for a reported pain level of 7-10. All participants will be provided the same
methods of postoperative pain control following their elective orthognathic surgery.

Inclusion Criteria:

- males and females 18-40 years of age undergoing elective double jaw orthognathic
surgery

Exclusion Criteria:

- pregnancy

- known hypersensitivity to any local anesthetic
We found this trial at
1
site
Boston, Massachusetts 02118
Phone: 617-638-4350
?
mi
from
Boston, MA
Click here to add this to my saved trials